In the evolving field of chemical biology and targeted protein degradation, the study of vhl binding peptide structures has become a cornerstone for researchers. As someone deeply interested in the mechanics of molecular recognition, I have spent significant time reviewing how these sequences interact wit Targeted protein degradation bypassing cereblon and von h the von Hippel-Lindau (VHL) protein. Understanding the intricacies of these interactions is essential, particularly when one considers that the VHL protein domain, specifica Small molecule ligands binding to VHL can function as inhibitors themselves or be applied in well-designed, effective PROTACs targeting various proteins. VHL lly the β domain, serves as a critical docking site for hydroxylated prolines.
The Mechanism of VHL Interaction
When we look at how polypeptides are able to bind to VHL, we are essentially observing a highly specific molecular "handshake." The core of this interaction relies on the trans-epimer of hydroxyproline. It is a well-documented observation in structural biology that the trans-epimer is an absolute requirement for binding; conversely, the cis-epimer effectively abrogates this process.
In my exploration of these compounds, I have noted that VHL is one of the most widely utilized E3 ligases, alongside Cereblon (CRBN). Researchers often utilize specific ligands to bridge the gap between a protein of interest (POI) and the E3 ligase machinery. A key insight here is that PROTACs are tripartite molecules consisting of a ligand for the POI, a linker, and a VHL recruiter.
Structural Insights and Peptide Utility
The versatility of the peptide modality cannot be overstated. Unlike traditional small molecules, Peptide PROTACs—such as the potent FPP29, which acts as a peptide-based FOXM1 PROTAC degrader—offer unique advantages, including structural flexibility and potential for multi-targeting.
However, it is important to maintain a realistic perspective on the landscape of this technology. Currently, PROTAC can only hijack less than 1% of E3 ligases in the body, including VHL, IAP, Keap1, and RNF4. This limitation drives the intens by J Jin · 2020 · Cited by 150 — The core concept of PROTAC is that this bifunctional molecule binds the POI at one end while binding an E3 ligase at the other end, which forms a ternary e interest in opti Journey of Von Hippel-Lindau (VHL) E3 ligase in mizing VHL binding affinity. For instance, VH-298 is a highly potent inhibitor of the VHL:HIF-α interaction with a Kd value in the range of 80 to 90 nM, illustrating the precision required in these designs.
Practical Considerations in Research
When analyzing the chemical structures of VHL ligands and their binding affinities, one must account for the physical state of the molecules. Studies have shown that there is more disorder in the peptide-like VHL binding region, and the linker component is often highly disordered, which can influence the stability of the ternary complex.
For those involved in experimental workflows, reagents such as VHL Ligand 1 HCl salt serve as standard benchmarks. When a bifunctional molecule binds von Hippel-Lindau (VHL) Control, Gene the POI at one end while simultaneously recruiting the E3 ligase, it forms a ternary complex that facilitates the catalytic degradation of the target. A prime example of this is seen in GMB-475, which is a proteolysis-targeting chimera (PROTAC) that allosterically targets BCR-ABL1.
Summary of Observations
My experience with these materials highlights a few critical takeaways fo Small molecule ligands binding to VHL can function as inhibitors themselves or be applied in well-designed, effective PROTACs targeting various proteins. VHL r any enthusiast or researcher:
* Specificity: The requirement for a specific hydroxyproline configuration is non-negotiable for effective VHL binding.
* Design Complexity: Whether using a small molecule like VH032 or a more complex peptide-based degrader, the linker leng E3 Ligase Ligands for PROTACs: How They Were Found th and rigidity are paramount to successful ternary complex formation.
* Evolving Landscape: While VHL remains a primary target, the field is constantly searching for novel E3 ligases to expand the current 1% threshold of hijackable proteins.
By focusing on the structural biology of these ligands, we gain a better appreciation for how these tools can be applied in advanced research. It is a fascinating intersection of chemistry and biology that continues to push the boundaries of molecular design.